Sichuan Hebang Biotechnology Co Ltd Financial Flexibility Index
Sichuan Hebang Biotechnology Co Ltd financial flexibility index. Sichuan Hebang Biotechnology Co Ltd (603077) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥366.16 Million (operating CF CN¥165.40 Million minus capex CN¥200.76 Million) represents 0% of total liabilities (CN¥10.53 Billion). Explore Sichuan Hebang Biotechnology Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Financial flexibility index of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. Historical Financial Flexibility Index trend for Sichuan Hebang Biotechnology Co Ltd across 17 annual periods. Check cash flow reinvestment rate of Sichuan Hebang Biotechnology Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Sichuan Hebang Biotechnology Co Ltd Financial Flexibility Index by Year (2009–2025)
Sichuan Hebang Biotechnology Co Ltd financial flexibility index by year from 2009 to 2025. Year-by-year free cash flow to debt coverage for Sichuan Hebang Biotechnology Co Ltd. For the full cash flow conversion analysis, see Sichuan Hebang Biotechnology Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥2.34 Billion | CN¥1.08 Billion | CN¥10.25 Billion | ▲ +53.1% |
| 2024 | 0.15x | CN¥1.58 Billion | CN¥467.93 Million | CN¥10.64 Billion | ▼ -37.5% |
| 2023 | 0.24x | CN¥1.03 Billion | CN¥200.76 Million | CN¥4.32 Billion | ▼ -71.1% |
| 2022 | 0.83x | CN¥3.58 Billion | CN¥2.64 Billion | CN¥4.34 Billion | ▼ -45.0% |
| 2021 | 1.50x | CN¥4.93 Billion | CN¥3.20 Billion | CN¥3.29 Billion | ▲ +810.5% |
| 2020 | 0.16x | CN¥565.95 Million | CN¥368.85 Million | CN¥3.43 Billion | ▼ -39.5% |
| 2019 | 0.27x | CN¥825.46 Million | CN¥162.92 Million | CN¥3.03 Billion | ▼ -56.5% |
| 2018 | 0.63x | CN¥1.31 Billion | CN¥944.39 Million | CN¥2.09 Billion | ▲ +67.6% |
| 2017 | 0.37x | CN¥685.48 Million | CN¥176.94 Million | CN¥1.83 Billion | ▼ -35.8% |
| 2016 | 0.58x | CN¥1.25 Billion | CN¥575.26 Million | CN¥2.15 Billion | ▲ +70.1% |
| 2015 | 0.34x | CN¥1.58 Billion | CN¥449.20 Million | CN¥4.62 Billion | ▲ +62.7% |
| 2014 | 0.21x | CN¥921.44 Million | CN¥204.67 Million | CN¥4.38 Billion | ▲ +152.4% |
| 2013 | 0.08x | CN¥191.06 Million | CN¥-407.48 Million | CN¥2.29 Billion | ▼ -66.5% |
| 2012 | 0.25x | CN¥408.79 Million | CN¥134.96 Million | CN¥1.64 Billion | ▼ -35.1% |
| 2011 | 0.38x | CN¥897.73 Million | CN¥552.56 Million | CN¥2.34 Billion | ▼ -8.8% |
| 2010 | 0.42x | CN¥901.77 Million | CN¥330.77 Million | CN¥2.14 Billion | ▲ +11.4% |
| 2009 | 0.38x | CN¥917.49 Million | CN¥68.97 Million | CN¥2.43 Billion | — |